New insights into the molecular basis of T cell anergy: Anergy factors, avoidance sensors, and epigenetic imprinting

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 7331-7341

  Wells, Andrew D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD28 ANTIGEN; CELL PROTEIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA INTERFERON; GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; JANUS KINASE 3; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE B; PROTEIN KINASE C THETA; PROTEIN P27; PROTEIN P50; RAP1 PROTEIN; RAS PROTEIN; STAT5 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNINDEXED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR;

ACETYLATION; ADAPTIVE IMMUNITY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL DEATH; CELL DIFFERENTIATION; CELL EXPANSION; CHROMATIN STRUCTURE; CLONAL ANERGY; CYTOKINE PRODUCTION; DEMETHYLATION; DNA BINDING; DNA MODIFICATION; EFFECTOR CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HEART GRAFT; HUMAN; IMMUNOPATHOLOGY; LONG TERM EXPOSURE; MEMORY T LYMPHOCYTE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION; ANIMAL; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; METABOLISM; REVIEW; T LYMPHOCYTE;

ANIMALS; CLONAL ANERGY; EPIGENESIS, GENETIC; HUMANS; INTERLEUKIN-2; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 67649160608     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803917     Document Type: Short Survey

References (90)

1. Choi, S., and R. H. Schwartz. 2007. Molecular mechanisms for adaptive tolerance and other T cell anergy models. Semin. Immunol. 19: 140-152.
2. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21: 305-334.
3. + T cells. Immunol. Rev. 211: 81-92.
4. Thompson, C. B., T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. G. Emerson, J. M. Leiden, and C. H. June. 1989. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86: 1333-1337.
5. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356: 607-609.
6. Jain, J., C. Loh, and A. Rao. 1995. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7: 333-342.
7. Serfling, E., A. Avots, and M. Neumann. 1995. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochim. Biophys. Acta. 1263: 181-200.
8. Kane, L. P., J. Lin, and A. Weiss. 2002. It's all Rel-ative: NF-κB and CD28 costimulation of T-cell activation. Trends Immunol. 23: 413-420.
9. Zarek, P. E., C. T. Huang, E. R. Lutz, J. Kowalski, M. R. Horton, J. Linden, C. G. Drake, and J. D. Powell. 2008. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111: 251-259.
10. Deaglio, S., K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J. F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204: 1257-1265.
11. Torgersen, K. M., T. Vang, H. Abrahamsen, S. Yaqub, and K. Tasken. 2002. Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell Signal. 14: 1-9.
12. + memory T cells. Nature 441: 890-893.
13. Seder, R. A., R. N. Germain, P. S. Linsley, and W. E. Paul. 1994. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon γ production. J. Exp. Med. 179: 299-304.
14. Malek, T. R. 2003. The main function of IL-2 is to promote the development of T regulatory cells. J. Leukocyte Biol. 74: 961-965.
15. Wells, A. D. 2007. Cyclin-dependent kinases: molecular switches controlling anergy and potential therapeutic targets for tolerance. Semin. Immunol. 19: 173-179.
16. Zheng, Y., S. L. Collins, M. A. Lutz, A. N. Allen, T. P. Kole, P. E. Zarek, and J. D. Powell. 2007. A role for mammalian target of rapamycin in regulating T cell activation versus anergy. J. Immunol. 178: 2163-2170. (Pubitemid 46233414)
17. Powell, J. D., C. G. Lerner, and R. H. Schwartz. 1999. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J. Immunol. 162: 2775-2784.
18. Buckler, J. L., P. T. Walsh, P. M. Porrett, Y. Choi, and L. A. Turka. 2006. Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN. J. Immunol. 177: 4262-4266.
19. + T cell proliferation and effector function. J. Immunol. 174: 3359-3368.
20. kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 6: 290-297.
21. kip1 is required for transplantation tolerance induced by costimulatory blockade. J. Immunol. 177: 5169-5176.
22. + T cells is due to defective signaling through the common γ-chain of the IL-2 receptor. J. Immunol. 164: 1175-1184.
23. Cip1 are not essential in T cell anergy. Eur. J. Immunol. 33: 3154-3163.
24. Kip1. Eur. J. Immunol. 31: 3737-3746.
25. Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev. 18: 862-876.
26. Wells, A. D., Q. H. Liu, B. Hondowicz, J. Zhang, L. A. Turka, and B. D. Freedman. 2003. Regulation of T cell activation and tolerance by phospholipase Cγ-1-dependent integrin avidity modulation. J. Immunol. 170: 4127-4133.
27. Heissmeyer, V., F. Macian, S. H. Im, R. Varma, S. Feske, K. Venuprasad, H. Gu, Y. C. Liu, M. L. Dustin, and A. Rao. 2004. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol. 5: 255-265.
28. Boussiotis, V. A., G. J. Freeman, A. Berezovskaya, D. L. Barber, and L. M. Nadler. 1997. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 278: 124-128.
29. Kip1. J. Biol. Chem. 277: 32413-32416.
30. Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat. Immunol. 7: 1157-1165.
31. Georgopoulos, K. 2002. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat. Rev. Immunol. 2: 162-174. (Pubitemid 37328763)
32. + T lymphocytes. J. Immunol. 179: 7305-7315.
33. Bunting, K., J. Wang, and M. F. Shannon. 2006. Control of interleukin-2 gene transcription: a paradigm for inducible, tissue-specific gene expression. Vitam. Horm. 74: 105-145.
34. + T lymphocytes. Science 256: 1452-1456.
35. + T cells. J. Biol. Chem. 279: 8460-8468.
36. Wang, J., S. Lee, C. E. Teh, K. Bunting, L. Ma, and M. F. Shannon. 2009. The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells. Int. Immunol. 21: 227-235.
37. Martins, G. A., L. Cimmino, J. Liao, E. Magnusdottir, and K. Calame. 2008. Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival. J. Exp. Med. 205: 1959-1965.
38. Tzachanis, D., G. J. Freeman, N. Hirano, A. A. van Puijenbroek, M. W. Delfs, A. Berezovskaya, L. M. Nadler, and V. A. Boussiotis. 2001. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat. Immunol. 2: 1174-1182.
39. Gajewski, T. F., P. Fields, and F. W. Fitch. 1995. Induction of the increased Fyn kinase activity in anergic T helper type 1 clones requires calcium and protein synthesis and is sensitive to cyclosporin A. Eur. J. Immunol. 25: 1836-1842.
40. 2-terminal kinase and mitogen-activated protein kinase signaling pathways. J. Exp. Med. 183: 2017-2023.
41. Jenkins, M. K., D. M. Pardoll, J. Mizuguchi, T. M. Chused, and R. H. Schwartz. 1987. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc. Natl. Acad. Sci. USA 84: 5409-5413.
42. Macian, F., F. Garcia-Cozar, S. H. Im, H. F. Horton, M. C. Byrne, and A. Rao. 2002. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109: 719-731.
43. + regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 106: 3068-3073.
44. + regulatory T Cells. J. Immunol. 177: 2186-2194.
45. Olenchock, B. A., R. Guo, J. H. Carpenter, M. Jordan, M. K. Topham, G. A. Koretzky, and X. P. Zhong. 2006. Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat. Immunol. 7: 1174-1181.
46. Zha, Y., R. Marks, A. W. Ho, A. C. Peterson, S. Janardhan, I. Brown, K. Praveen, S. Stang, J. C. Stone, and T. F. Gajewski. 2006. T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-α. Nat. Immunol. 7: 1166-1173.
47. Mueller, D. L. 2004. E3 ubiquitin ligases as T cell anergy factors. Nat. Immunol. 5: 883-890.
48. Puga, I., A. Rao, and F. Macian. 2008. Targeted cleavage of signaling proteins by caspase 3 inhibits T cell receptor signaling in anergic T cells. Immunity 29: 193-204.
49. King, C. G., J. L. Buckler, T. Kobayashi, J. R. Hannah, G. Bassett, T. Kim, E. L. Pearce, G. G. Kim, L. A. Turka, and Y. Choi. 2008. Cutting edge: requirement for TRAF6 in the induction of T cell anergy. J. Immunol. 180: 34-38.
50. Schartner, J. M., C. G. Fathman, and C. M. Seroogy. 2007. Preservation of self: an overview of E3 ubiquitin ligases and T cell tolerance. Semin. Immunol. 19: 188-196.
51. Safford, M., S. Collins, M. A. Lutz, A. Allen, C. T. Huang, J. Kowalski, A. Blackford, M. R. Horton, C. Drake, R. H. Schwartz, and J. D. Powell. 2005. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat. Immunol. 6: 472-480.
52. + T cells. J. Immunol. 173: 7331-7338.
53. Bandyopadhyay, S., M. Dure, M. Paroder, N. Soto-Nieves, I. Puga, and F. Macian. 2006. Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells. Blood 109: 2878-2886.
54. Bodor, J., and J. F. Habener. 1998. Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes. J. Biol. Chem. 273: 9544-9551.
55. Powell, J. D., C. G. Lerner, G. R. Ewoldt, and R. H. Schwartz. 1999. The - 180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy. J. Immunol. 163: 6631-6639.
56. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24: 209-226.
57. Tone, Y., K. Furuuchi, Y. Kojima, M. L. Tykocinski, M. I. Greene, and M. Tone. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9: 194-202.
58. Wu, Y., M. Borde, V. Heissmeyer, M. Feuerer, A. D. Lapan, J. C. Stroud, D. L. Bates, L. Guo, A. Han, S. F. Ziegler, et al. 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375-387.
59. Chen, C., E. A. Rowell, R. M. Thomas, W. W. Hancock, and A. D. Wells. 2006. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J. Biol. Chem. 281: 36828-36834.
60. Zheng, Y., S. Z. Josefowicz, A. Kas, T. T. Chu, M. A. Gavin, and A. Y. Rudensky. 2007. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445: 936-940.
61. Marson, A., K. Kretschmer, G. M. Frampton, E. S. Jacobsen, J. K. Polansky, K. D. Macisaac, S. S. Levine, E. Fraenkel, H. von Boehmer, and R. A. Young. 2007. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931-935.
62. Lee, S. M., B. Gao, and D. Fang. 2008. FoxP3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1. Blood 111: 3599-3606.
63. Chang, X., L. Chen, J. Wen, V. L. Godfrey, G. Qiao, Y. Hussien, J. Zhang, and J. X. Gao. 2006. Foxp3 controls autoreactive T cell activation through transcriptional regulation of early growth response genes and E3 ubiquitin ligase genes, independently of thymic selection. Clin. Immunol. 121: 274-285.
64. Telander, D. G., E. N. Malvey, and D. L. Mueller. 1999. Evidence for repression of IL-2 gene activation in anergic T cells. J. Immunol. 162: 1460-1465.
65. Kitagawa-Sakakida, S., and R. H. Schwartz. 1996. Multifactor cis-dominant negative regulation of IL-2 gene expression in anergized T cells. J. Immunol. 157: 2328-2339. (Pubitemid 126450442)
66. Wells, A. D., M. C. Walsh, J. A. Bluestone, and L. A. Turka. 2001. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J. Clin. Invest. 108: 895-903.
67. Colombetti, S., F. Benigni, V. Basso, and A. Mondino. 2002. Clonal anergy is maintained independently of T cell proliferation. J. Immunol. 169: 6178-6186. (Pubitemid 36903463)
68. Yui, M. A., G. Hernandez-Hoyos, and E. V. Rothenberg. 2001. A new regulatory region of the IL-2 locus that confers position-independent transgene expression. J. Immunol. 166: 1730-1739. (Pubitemid 32114657)
69. Adachi, S., and E. V. Rothenberg. 2005. Cell-type-specific epigenetic marking of the IL2 gene at a distal cis-regulatory region in competent, nontranscribing T-cells. Nucleic Acids Res. 33: 3200-3210.
70. Thomas, R. M., L. Gao, and A. D. Wells. 2005. Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J. Immunol. 174: 4639-4646. (Pubitemid 40504545)
71. + T cell tolerance is associated with DNA methylation and histone hypo-acetylation at cytokine gene loci. Genes Immun. 8: 613-618.
72. Tenbrock, K., Y. T. Juang, N. Leukert, J. Roth, and G. C. Tsokos. 2006. The transcriptional repressor cAMP response element modulator α interacts with histone deacetylase 1 to repress promoter activity. J. Immunol. 177: 6159-6164. (Pubitemid 44628833)
73. + T-cell memory: only the good ones last. Curr. Opin. Immunol. 16: 451-455.
74. Northrop, J. K., R. M. Thomas, A. D. Wells, and H. Shen. 2006. Epigenetic remodeling of the IL-2 and IFN-γ loci in memory CD8 T cells is influenced by CD4 T cells. J. Immunol. 177: 1062-1069.
75. + regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene. J. Immunol. 173: 4994-5001.
76. Tao, R., E. F. de Zoeten, E. Ozkaynak, C. Chen, L. Wang, P. M. Porrett, B. Li, L. A. Turka, E. N. Olson, M. I. Greene, et al. 2007. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13: 1299-1307.
77. Grant, C., U. Oh, K. Fugo, N. Takenouchi, C. Griffith, K. Yao, T. E. Newhook, L. Ratner, and S. Jacobson. 2006. Foxp3 represses retroviral transcription by targeting both NF-κB and CREB pathways. PLoS Pathog. 2: e33.
78. Li, B., A. Samanta, X. Song, K. T. Iacono, K. Bembas, R. Tao, S. Basu, J. L. Riley, W. W. Hancock, Y. Shen, et al. 2007. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. USA 104: 4571-4576.
79. Takahashi, I., H. Miyaji, T. Yoshida, S. Sato, and T. Mizukami. 1996. Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase. J. Antibiot. (Tokyo) 49: 453-457.
80. Jackson, S. K., A. DeLoose, and K. M. Gilbert. 2002. The ability of antigen, but not interleukin-2, to promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and altered association patterns of cyclin-dependent kinase inhibitors. Immunology 106: 486-495.
81. Matsuoka, H., T. Fujimura, M. Hayashi, K. Matsuda, Y. Ishii, I. Aramori, and S. Mutoh. 2007. Disruption of HDAC4/N-CoR complex by histone deacetylase inhibitors leads to inhibition of IL-2 gene expression. Biochem. Pharmacol. 74: 465-476.
82. Ansel, K. M., D. U. Lee, and A. Rao. 2003. An epigenetic view of helper T cell differentiation. Nat. Immunol. 4: 616-623.
83. Northrop, J. K., A. D. Wells, and H. Shen. 2008. Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells. J. Immunol. 181: 865-868.
84. Lee, P. P., D. R. Fitzpatrick, C. Beard, H. K. Jessup, S. Lehar, K. W. Makar, M. Perez-Melgosa, M. T. Sweetser, M. S. Schlissel, S. Nguyen, et al. 2001. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15: 763-774.
85. Makar, K. W., and C. B. Wilson. 2004. DNA methylation is a nonredundant repressor of the Th2 effector program. J. Immunol. 173: 4402-4406.
86. Winders, B. R., R. H. Schwartz, and D. Bruniquel. 2004. A distinct region of the murine IFN-γ promoter is hypomethylated from early T cell development through mature naive and Th1 cell differentiation, but is hypermethylated in Th2 cells. J. Immunol. 173: 7377-7384.
87. + T lymphocytes. J. Immunol. 162: 5053-5057.
88. Bruniquel, D., and R. H. Schwartz. 2003. Selective, stable demethylation of the interleukin- 2 gene enhances transcription by an active process. Nat. Immunol. 4: 235-240.
89. Murayama, A., K. Sakura, M. Nakama, K. Yasuzawa-Tanaka, E. Fujita, Y. Tateishi, Y. Wang, T. Ushijima, T. Baba, K. Shibuya, et al. 2006. A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. EMBO J. 25: 1081-1092.
90. Kersh, E. N., D. R. Fitzpatrick, K. Murali-Krishna, J. Shires, S. H. Speck, J. M. Boss, and R. Ahmed. 2006. Rapid demethylation of the IFN-γ gene occurs in memory but not naive CD8 T cells. J. Immunol. 176: 4083-4093.